Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19
- Conditions
- Infectious
- Registration Number
- NCT04490772
- Lead Sponsor
- Assiut University
- Brief Summary
Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.
- Detailed Description
Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients:
Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation.
Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin.
Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- Confirmed Covid-19 with GIT manifestations
- Patients refuse to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method liver function test 2 months Laboratory characters
Clinical data questionnaire 2 months Clinical characteristics of age, sex, comorbidities and symptoms.
Tests such as CBC 2 months Laboratory characters
- Secondary Outcome Measures
Name Time Method